GoldMiner Search
 
J Nucl Med 2017; 58:1360-1366<br/><hr/><font size=1>(A) Dx head/neck (top) and chest (bottom) CT (DLP = 139 mGy-cm; estimated ED = 2.2 mSv) acquired before the PET/CT scan. (B) Multiseries ...</font>

J Nucl Med 2017

J Nucl Med 2017; 58:1360-1366<br/><hr/><font size=1>ED estimates (in mSv) from CT for a 10-y-old under the various scenarios illustrated in.</font>

J Nucl Med 2017

J Nucl Med 2017; 58:1360-1366<br/><hr/><font size=1>Attenuation correction (non-Dx) and Dx CT ED. ED estimates (in mSv) for Dx and non-Dx CT for various ages from a 1-y-old to a ...</font>

J Nucl Med 2017

J Nucl Med 2017; 58:1360-1366<br/><hr/><font size=1>Visual representation of the 5 imaging scenarios for a 10-y-old child (red = Dx CT; pink = non-Dx CT). Scenario 1 is torso Dx ...</font>

J Nucl Med 2017

J Nucl Med 2017; 58:1360-1366<br/><hr/><font size=1>Example of AEC. The underlying image is a CT topogram of a chest CT. The white profile indicates the mAs as a function of ...</font> J Nucl Med 2017
J Nucl Med 2016; 57:1364-9<br/><hr/><font size=1>Overview of study population. CCTA = coronary CT angiography; ECG = electrocardiogram.</font> J Nucl Med 2016
J Nucl Med 2016; 57:1170-6<br/><hr/><font size=1>Imaging-based response evaluation. (A) Ga-68-PSMA-11 PET was evaluated semiquantitatively. (B) Tc-99m-MIP1427 scintigraphy&151;enabled visual evaluation. (C) If target lesions were available, CT was evaluated in ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:1221-5<br/><hr/><font size=1>Measurement of BAT uptake. Supraclavicular fat was identified using CT density thresholds (HU 50 to 250). BAT F-18-FDG uptake was assessed by manually drawing ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:1350-6<br/><hr/><font size=1>A 48-y-old woman with estrogen receptor&151;positive human epidermal growth factor receptor 2&151;negative IDC. (A) Axial F-18-fluciclovine PET, CT, and fused F-18-fluciclovine PET/CT demonstrating primary ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:1296-301<br/><hr/><font size=1>Decrease in perfused pulmonary volume by radiation, as determined by ratio of Tc-99m-MAA SPECT perfused volume to coregistered CT anatomic volume. Line is median ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:1296-301<br/><hr/><font size=1>Typical Tc-99m-MAA (left) and Tc-99m-Duramycin (right) transaxial slices from reconstructed volumes obtained from control (top) and 15-Gy&151;irradiated (bottom) rats. Color images represent segmented SPECT ...</font>

J Nucl Med 2016

Neurology 2017; 88(24):2248-2253<br/><hr/><font size=1>Noncontrast CT, core (red) and penumbra (green) CT perfusion maps, and acute diffusion-weighted imaging (DWI) MRI in 3 different patients (A) Agreement among all ...</font>

Neurology 2017

J Nucl Med 2016; 57:1045-51<br/><hr/><font size=1>Images of representative cases. (A&151;C) 65-y-old man who presented with hepatic tumor (arrows) on enhanced CT (A), which showed high TBRIVCmax (2.59) and UVPIVC ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:1091-5<br/><hr/><font size=1>A 70-y-old man (height, 1.73 m; weight, 71 kg; body mass index, 24 kg/m2) referred for prostate cancer staging bone scanning (injection of 640 ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:1052-7<br/><hr/><font size=1>Quantitative PET/CT image analysis. (A) Axial unenhanced CT scan of ablated zone (arrow), providing no information on treatment effectiveness. (B) Positioning of two 3-dimensional ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:918-24<br/><hr/><font size=1>Visual comparison between CT -maps (A and B) and model B -maps (C and D) for 2 individual subjects selected with high (left) and ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:918-24<br/><hr/><font size=1>Estimation of mean bias for MR-based AC methods in medial temporal lobe structures (color scale bar = SUVmean bias compared with CT). First panel ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:918-24<br/><hr/><font size=1>Surface maps of mean F-18-FDG PET SUV bias between CT and MR-based AC methods (n = 16 subjects, scale bar = mean bias as ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:918-24<br/><hr/><font size=1>Comparison of F-18-FDG PET surface maps for left hemisphere in subject with clinical and imaging features consistent with mild Alzheimer dementia (top and bottom ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:879-85<br/><hr/><font size=1>An 87-y-old patient with FIGO stage III C1 and endometrioid grade 2. (A) Contrast-enhanced CT depicting nonenlarged lymph node (arrow) close to right internal ...</font>

J Nucl Med 2016

J Nucl Med Technol 2016; 44:73-7<br/><hr/><font size=1>Eight sets of cardiac PET/CT images, including reference without misregistration (A) and 7 different degrees of artificial misregistration between PET and CT images in ...</font> J Nucl Med Technol 2016
J Nucl Med Technol 2016; 44:73-7<br/><hr/><font size=1>Manual registration of PET and CT-attenuation images. PET image was moved over CT image in transaxial (A), coronal (B), and sagittal (C) views with ...</font> J Nucl Med Technol 2016
J Nucl Med 2016; 57:886-92<br/><hr/><font size=1>Incidental finding of fibrous dysplasia on NaF-18 PET/CT. Right nasal bone appears characteristically opaque and expansile. Left image is axial CT scan of skull ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:913-7<br/><hr/><font size=1>Example images of participant: T1-weighted MR (A), Dixon -map (B), CT -map (C), non&151;attenuation-corrected PET (D), PET with Dixon MRAC (E), and PET with ...</font> J Nucl Med 2016
Eur J Endocrinol 2015; 173:325-32<br/><hr/><font size=1>Relationship between cortisol secretion and unenhanced CT attenuation value. The x-axis represents the level of diurnal cortisol secretion expressed as 24-h urine free cortisol ...</font>

Eur J Endocrinol 2015

Eur J Endocrinol 2015; 173:M107-20<br/><hr/><font size=1>Case 6: C-11-methionine PET&151;CT co-registered with SPGR MRI shows minimal tracer uptake in the sella in a patient with a possible lesion on dynamic ...</font>

Eur J Endocrinol 2015

Eur J Endocrinol 2015; 173:M107-20<br/><hr/><font size=1>Case 5: C-11-methionine PET&151;CT co-registered with SPGR MRI identifies the site of a previously unsuspected corticotroph microadenoma in a patient with persistent Cushing\\\'s disease ...</font>

Eur J Endocrinol 2015

Eur J Endocrinol 2015; 173:M107-20<br/><hr/><font size=1>Case 4: C-11-methionine PET&151;CT co-registered with SPGR MRI confirms the site of recurrence in a patient with relapsed Cushing\\\'s disease following first TSS. (a ...</font>

Eur J Endocrinol 2015

Eur J Endocrinol 2015; 173:M107-20<br/><hr/><font size=1>Case 3: C-11-methionine PET&151;CT co-registered with SPGR MRI identifies a left-sided microadenoma that is not readily visualised on initial MRI, in a patient with ...</font> Eur J Endocrinol 2015
Eur J Endocrinol 2015; 173:M107-20<br/><hr/><font size=1>Case 2: C-11-methionine PET&151;CT co-registered with SPGR MRI aids identification of a small microadenoma that is suspected on initial MRI. (a and b) T1-weighted ...</font> Eur J Endocrinol 2015
Eur J Endocrinol 2015; 173:M107-20<br/><hr/><font size=1>Case 1: C-11-methionine PET&151;CT co-registered with SPGR MRI confirms functionality within an easily visualised right-sided corticotroph microadenoma. (a and b) T1-weighted coronal SE MRI ...</font> Eur J Endocrinol 2015
CMAJ 2016; 188:447<br/><hr/><font size=1>Computed tomographic (CT) images at (A) the level of the cricoid cartilage and (B) the level of the cervical trachea of the neck of ...</font> CMAJ 2016
The BMJ 2017; 356():<br/><hr/><font size=1>Fig 1Lung cancers and major cancers theoretically induced per 10000 people screened, according to sex and age at start of CT screening for lung ...</font>

The BMJ 2017

J Nucl Med 2016; 57:582-6<br/><hr/><font size=1>(A) For each of 161 lung lesions, difference between size on MRI component of PET/MRI and size on CT component of PET/CT is plotted ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:582-6<br/><hr/><font size=1>In 46-y-old woman with breast cancer, 4-mm nodule (arrows) is seen in lingula segment of left upper lobe of lung on CT component (A) ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:582-6<br/><hr/><font size=1>In 65-y-old woman with lung cancer, 38-mm tumor (arrows) is seen in right upper lobe of lung on CT component (A) of PET/CT (C) ...</font>

J Nucl Med 2016

J Nucl Med 2016; 57:587-93<br/><hr/><font size=1>Attenuation maps and F-18-FDG PET images corrected using them. (A) CT. (B) MR-ACmMR using mMR software version VB20P. (C) MR-AClevel.</font> J Nucl Med 2016
J Nucl Med 2016; 57:587-93<br/><hr/><font size=1>Attenuation maps and F-18-FP-CIT PET images corrected using them. (A) CT. (B) MR-ACmMR: MR-based attenuation map generated using mMR software version VB18P. (C) MR-AClevel: ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:557-62<br/><hr/><font size=1>67-y-old man with history of Gleason 3 + 3 prostate cancer treated with radiation therapy and androgen blockade, who presented with PSA level of ...</font> J Nucl Med 2016
J Nucl Med 2016; 57:557-62<br/><hr/><font size=1>83-y-old man with history of Gleason 5 + 4 prostate cancer treated with radiation therapy and androgen blockade, who presented with PSA level of ...</font> J Nucl Med 2016

ARRS Member?

If you are...

If you aren't...

...so you can earn CME credit for your GoldMiner searches.

1 - 40 · Next »  
Copyright © 2017, American Roentgen Ray Society facebook.com/ARRSGoldMiner   @ARRS_GoldMiner ARRS GoldMiner® is a registered trademark of the American Roentgen Ray Society.